Market Tracker

05/25 6:35am ET

ImmunoGen Inc (NASDAQ:IMGN)

10.58
Delayed Data
As of May 24
 +0.20 / +1.93%
Today’s Change
4.26
Today|||52-Week Range
13.41
+65.05%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close10.38
Today’s open10.44
Day’s range10.39 - 10.65
Volume873,550
Average volume (3 months)3,018,784
Market cap$1.4B
Data as of 4:00pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)+45.86%
Earnings growth (this year)-15.71%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+168.41%
P/E ratioNM
Price/Sales5.45
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...+0.30+1.96%
NTLAIntellia Therapeutic...+0.26+1.02%
BOLDAudentes Therapeutic...+0.66+1.80%
AMAGAMAG Pharmaceuticals...-0.05-0.22%
Data as of 4:00pm ET, 05/24/2018

Financials

Next reporting dateJuly 27, 2018
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$115.4M
Annual profit (last year)-$96.0M
Net profit margin-83.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts